John M. McCall - Concepedia

Author

John M. McCall

W.E. Upjohn Institute for Employment Research

Also Known As

JOHN M. MCCALL, JOHN M. McCALL, John M. MCCALL, John M. McCALL, John M. McCall, John M. Mccall, McCall, John M.

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

W.E. Upjohn Institute for Employment Research ReveraGen BioPharma (United States)Children's National George Washington University CNS Research (United States)

About

John M. McCall is an author at W.E. Upjohn Institute for Employment Research specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.2K
2	Natural Sciences	5	5	643
3	Engineering	4	4	171
4	Health Sciences	3	3	357
5	Allergy	1	1	17

John M. McCall

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
A call for transparent reporting to optimize the predictive value of preclinical research Story C. Landis, Susan Amara, Khusru Asadullah, Nature	2012	1.2K
[3H]U-69593 a highly selective ligand for the opioid κ receptor Robert A. Lahti, Mary M. Mickelson, John M. McCall, European Journal of Pharmacology Molecular PharmacologyDrug TargetBiochemistryMedicineNatural Sciences	1985	445
Effects of the 21-aminosteroid U74006F on experimental head injury in mice Edward D. Hall, Patricia A. Yonkers, John M. McCall, Journal of neurosurgery Traumatic Brain InjuryLipid PeroxidationHead InjuryOxidative StressCerebral Vascular Regulation	1988	296
Liquid-liquid partition coefficients by high-pressure liquid chromatography John M. McCall Journal of Medicinal Chemistry	1975	217
VBP15, a novel anti‐inflammatory and membrane‐stabilizer, improves muscular dystrophy without side effects Christopher R. Heier, Jesse M. Damsker, Qing Yu, EMBO Molecular Medicine	2013	188
Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury Douglas K. Anderson, J. Mark Braughler, Edward D. Hall, Journal of neurosurgery	1988	160
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug Laurie S. Conklin, Jesse M. Damsker, Eric P. Hoffman, Pharmacological Research	2018	93
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function Eric P. Hoffman, Benjamin D. Schwartz, L. Mengle-Gaw, Neurology	2019	90
Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma E. Jon Jacobsen, John M. McCall, Donald E. Ayer, Journal of Medicinal Chemistry Lipid PeroxidationPharmacotherapyRedox BiologyOxidative StressNeuroinflammation	1990	89
Pyrimidine and triazine 3-oxide sulfates: a new family of vasodilators John M. McCall, James W. Aiken, C. G. CHIDESTER, Journal of Medicinal Chemistry Direct VasodilationInorganic ChemistryMedicinal ChemistryNew FamilyBioorganic Chemistry	1983	72

Page 1